Below is a list of medicines authorized in the European Union (EU) to treat or prevent COVID-19, following a scientific evaluation by the European Medicines Agency (EMA). It provides details of other potential treatments and vaccines that the EMA is evaluating or supporting during research and development.

What is COVID-19?

COVID-19 is a disease caused by the virus called severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2). SARS-CoV-2 is a new strain of coronavirus that was not detected in humans until December 2019.

The current COVID-19 outbreak broke out in late 2019 and was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. It is the first pandemic caused by a coronavirus.

There are many different types of coronaviruses. Although they mainly affect animals, some can infect humans.

Medicines and vaccines used to treat COVID-19 (SARS-CoV-2)

Below is a list of medicines authorized in the European Union (EU) to treat or prevent COVID-19, following a scientific evaluation by the European Medicines Agency (EMA). It provides details of other potential treatments and vaccines that the EMA is evaluating or supporting during research and development.

EMA authorized treatments in the EU for COVID-19 (SARS-CoV-2)

PAXLOVID 150mg+100mg (PF-07321332 + ritonavir) • [leaflet updated 29/04/2022]

Kineret 150mg/ml (anakinra) • [leaflet updated 22/12/2021]

Regkirona 60mg/ml (regdanvimabum) • [leaflet updated 13/04/2022]

RoActemra 80mg , 162mg , 200mg , 400mg (tocilizumabum) • [leaflet updated 26/04/2022]

Ronapreve 120mg/ml+120mg/ml , 300mg+300mg (casirivimabum + imdevimabum) • [leaflet updated 18/03/2022]

Veklury 100mg (remdesivir) • [leaflet updated 28/03/2022]

Xevudy 500mg (sotrovimab) • [leaflet updated 06/05/2022]

Treatments with Marketing authorisation application submitted to EMA for COVID-19 (SARS-CoV-2)

Lagevrio 200mg (molnupiravir) - Authorized only in UK • [leaflet published 04/11/2011]

Olumiant 2mg , 4mg (baricitinibum) • [leaflet updated 29/11/2021]